ALK and non-small cell lung carcinoma: Produced from the EML4-ALK fusion, circRNA F-circEA-2a reveals positive effect on cell invasion and migration in NSCLC, highlighting its critical role in EML4-ALK-positive NSCLC (Tan et al., 2018).